Loading…

Cytokine Modulation Correlates Strongly with Symptom Improvement in Patients with Myelofibrosis Treated with Nuvisertib (TP-3654), an Investigational Selective PIM1 Kinase Inhibitor

Saved in:

Bibliographic Details
Published in:	Blood 2024-11, Vol.144 (Supplement 1), p.3179-3179
Main Authors:	Rein, Lindsay A.M., El Chaer, Firas, Yuda, Junichiro, Shimoda, Kazuya, Rampal, Raajit, Scandura, Joseph M., Takami, Akiyoshi, McCloskey, James, Ichii, Michiko, Shirane, Shuichi, Iurlo, Alessandra, Bose, Prithviraj, Lucchesi, Alessandro, Benevolo, Giulia, Amanam, Idoroenyi, Vachhani, Pankit, Tantravahi, Srinivas K, Rotta, Marcello, Onishi, Yasushi, Kiladjian, Jean-Jacques, Rinaldi, Ciro, Granacher, Nikki, Bradley, Terrence, Patel, Anand Ashwin, Loschi, Michael, Alimam, Samah, Cheung, Stanley, Ribrag, Vincent, Kabir, Sujan, Seki, Masataka, Ansaldo, Karen, Guffanti, Guia, Lee, Jinny, Warner, Steven L., Foulks, Jason M., Mesa, Ruben
Format:	Article
Language:	English
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!